IRIS
CROTTI, LIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.419
AS - Asia 4.277
EU - Europa 3.367
SA - Sud America 511
AF - Africa 150
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 9
Totale 13.765
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.268
CN - Cina 2.127
SG - Singapore 923
IE - Irlanda 802
HK - Hong Kong 448
IT - Italia 410
UA - Ucraina 388
RU - Federazione Russa 369
DE - Germania 368
VN - Vietnam 359
BR - Brasile 357
FI - Finlandia 353
FR - Francia 208
GB - Regno Unito 189
SE - Svezia 107
CA - Canada 94
BD - Bangladesh 93
IN - India 85
ZA - Sudafrica 79
AR - Argentina 64
IQ - Iraq 41
BE - Belgio 35
MX - Messico 33
JP - Giappone 31
PL - Polonia 25
EC - Ecuador 22
AT - Austria 21
CO - Colombia 21
NL - Olanda 21
AU - Australia 19
PK - Pakistan 19
TR - Turchia 19
PH - Filippine 17
VE - Venezuela 17
MA - Marocco 15
ES - Italia 14
KE - Kenya 12
NZ - Nuova Zelanda 12
UZ - Uzbekistan 12
MY - Malesia 11
TN - Tunisia 11
SA - Arabia Saudita 10
CL - Cile 9
ID - Indonesia 9
JO - Giordania 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
DZ - Algeria 7
ET - Etiopia 7
KR - Corea 7
KZ - Kazakistan 7
PE - Perù 7
RO - Romania 7
CH - Svizzera 6
DO - Repubblica Dominicana 6
EG - Egitto 6
EU - Europa 6
IR - Iran 6
AL - Albania 5
AZ - Azerbaigian 5
BG - Bulgaria 5
CR - Costa Rica 5
CZ - Repubblica Ceca 5
DK - Danimarca 5
IL - Israele 5
KG - Kirghizistan 5
NP - Nepal 5
PY - Paraguay 5
GR - Grecia 4
LT - Lituania 4
LU - Lussemburgo 4
NI - Nicaragua 3
OM - Oman 3
PA - Panama 3
PT - Portogallo 3
BB - Barbados 2
HU - Ungheria 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LV - Lettonia 2
LY - Libia 2
NO - Norvegia 2
QA - Qatar 2
TH - Thailandia 2
UY - Uruguay 2
ZW - Zimbabwe 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GI - Gibilterra 1
GN - Guinea 1
HN - Honduras 1
Totale 13.752
Salva come PNG Salva come JPEG
Città #
Dublin 799
Chandler 708
Ashburn 498
San Jose 498
Jacksonville 493
Singapore 470
Hong Kong 438
Nanjing 436
Beijing 391
Dallas 379
Boardman 207
Nanchang 171
Wilmington 145
Ho Chi Minh City 141
Princeton 140
Lawrence 138
Shenyang 135
Lauterbourg 129
Los Angeles 127
Changsha 121
Helsinki 120
Hebei 119
Ann Arbor 118
Jiaxing 108
New York 101
Medford 97
Milan 97
Hanoi 83
Council Bluffs 72
Johannesburg 72
Hangzhou 71
Shanghai 67
Pavia 66
Tianjin 63
Redondo Beach 61
Buffalo 60
Moscow 59
Munich 49
Toronto 44
São Paulo 40
Woodbridge 36
Frankfurt am Main 32
Orem 31
Tokyo 31
Brussels 29
Houston 28
Seattle 28
Norwalk 27
Santa Clara 27
Nuremberg 24
Verona 24
Falkenstein 23
Fairfield 21
Turku 21
Warsaw 20
Brooklyn 19
London 19
Ottawa 19
Baghdad 18
Zhengzhou 18
Chennai 17
Denver 17
San Francisco 17
Chicago 16
Des Moines 16
Kunming 16
Manchester 16
Atlanta 14
Falls Church 14
Haiphong 14
The Dalles 14
Trieste 14
Boston 13
Guangzhou 13
Bergamo 12
City of London 12
Montreal 12
Phoenix 12
Pune 12
Stockholm 12
Amsterdam 11
Florence 11
Jinan 11
Nairobi 11
Tashkent 11
Columbus 10
Belo Horizonte 9
Da Nang 9
Dhaka 9
Hải Dương 9
Mexico City 9
Piscataway 9
Poplar 9
Quito 9
Amman 8
Berlin 8
Buenos Aires 8
Mumbai 8
Rochester 8
Secaucus 8
Totale 9.094
Salva come PNG Salva come JPEG
Nome #
Mapping the human genetic architecture of COVID-19 302
A first update on mapping the human genetic architecture of COVID-19 193
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. 186
Long QT and short QT syndromes. 160
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome. 146
PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis. 143
Gene symbol: KCNH2 140
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 140
Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome. 137
Spectrum and prevalence of mutations involving BrS1-12 susceptibility genes in a cohort of unrelated patients referred for Brugada Syndrome genetic testing: implications for genetic testing. 136
FGF12 is a candidate Brugada syndrome locus. 133
Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1. 131
AKAP9 is a genetic modifier of congenuital Long-QT Syndrome type 1 126
Long QT syndrome-associated mutations in intrauterine fetal death. 126
Novel human pathological mutations. Gene symbol: SCN5A. Disease: Brugada Syndrome. 122
Cardiac arrhythmias of genetic origin are important contributors to Sudden Infant Death Syndrome. 118
Electrocardiographic and genetic screening for long QT syndrome: results from a prospective study on 44,596 neonates. 118
Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study 117
The genetics underlying acquired long QT syndrome: impact for genetic screening. 116
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 116
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 115
Inherited cardiac arrhythmia syndrome. Role of potassium channels 114
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents. 114
Cardiac potassium channel dysfunction in sudden infant death syndrome. 113
Arrhythmogenic disorders of genetic origin. Long QT Syndrome: from genetics to management. 113
A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5. 113
The LQT2 KCNH2-Q376Q splicing muation: functional characterization, molecular correction and therapeutic implication. 112
All LQT3 patients need an ICD. True or false? 112
Cardiac sodium channel dysfunction in sudden infant death syndrome. 112
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation 112
Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3′ Untranslated Region of KCNQ1? 112
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 112
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 111
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene 111
QT lungo, sindrome del 108
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model 108
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1 108
KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome. 106
A comprehensive electrocardiographic, molecular, and echocardiographic study of Brugada syndrome: validation of the 2013 diagnostic criteria. 106
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 105
Prevalence of the congenital long-QT syndrome. 104
Individual autonomic profile contributes to the risk for life-threatening arrhythmias among KCNQ1-A341V mutation carriers 103
Brugada and Long QT Syndrome are two different diseases: True or False? 103
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2 103
An International Multi-Center Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition. 103
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. 102
The ICD for the long QT syndrome: which indications, complications, and results? 101
Can a message from the dead save lives? 101
A Refined Multiscale Self-Entropy Approach for the Assessment of Cardiac Control Complexity: Application to Long QT Syndrome Type 1 Patients 100
KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. 100
Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients. 99
Response to Letters Regarding Article, "Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation" 99
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation 99
NOS1AP Is a Genetic Modifier of the Long-QT Syndrome 98
Impact of clinical and genetic findings on the management of young patients with Brugada syndrome. 98
Genotype-Phenotype Correlation in Induced Pluripotent Stem Cell (iPSC) Derived Cardiomyocytes Carrying Calmodulin Mutations 98
Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population 98
Arrhythmogenic calmodulin mutations disrupt intracellular cardiomyocyte Ca2+ regulation by distinct mechanisms. 97
Congenital long QT and short QT syndromes 97
Autonomic control of heart rate and QT interval variability influences arrhythmic risk in long QT syndrome type 1 96
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi006-A from a patient affected by an autosomal recessive form of long QT syndrome type 1 96
Risk factors for primary ventricular fibrillation during a first myocardial infarction: Clinical findings from PREDESTINATION (PRimary vEntricular fibrillation and suDden dEath during firST myocardIal iNfArcTION) 96
Idiopathic Ventricular Fibrillation. 95
Cadherin 2-Related Arrhythmogenic Cardiomyopathy: Prevalence and Clinical Features 94
Torsades de Pointes following Acute Myocardial Infarction: Evidence for a Deadly Link with a Common Genetic Variant. 93
Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. 92
Filtering approach based on empirical mode decomposition improves the assessment of short scale complexity in long QT syndrome type 1 population 92
Clinical management of catecholaminergic polymorphic ventricular tachycardia the role of left cardiac sympathetic denervation 91
Gene symbol: SCN5A 90
Condizioni cliniche associate ad anomalie dell'intervallo QT: Implicazioni cliniche [Clinical conditions associated with abnormal QT interval: clinical implications]. 90
Clinical implications for patients with Long QT Syndrome who experience a cardiac event during infancy 90
QTc behavior during exercise and genetic testing for the long-QT syndrome. 89
Functional characterization and molecular correction of the LQT2 KCNH2-Q376 splicing mutation. Therapeutic implications? 88
Gene symbol: KCNH2 88
Time, frequency and information domain analysis of heart period and QT variability in asymptomatic long QT syndrome type 2 patients. 88
Calmodulin mutations associated with recurrent cardiac arrest in infants. 88
Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation. 87
Novel calmodulin mutations associated with congenital arrhythmia susceptibility. 86
Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study. 86
The Long QT Syndrome 85
Two cases of sudden unexpected death in epilepsy in a GEFS+ family with an SCN1A mutation. 85
The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. 85
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes 85
Mutation-specific risk in two genetic forms of type 3 long QT syndrome. 84
Symbolic analysis of heart period and QT interval variabilities in LQT1 patients 84
High efficacy of beta-blockers in Long QT Syndrome type 1: contribution of non-compliance and QT-prolonging drugs to the occurrence of beta-blocker treatment “failures”. 83
Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility (Nature Genetics, (2022), 54, 3, (232-239), 10.1038/s41588-021-01007-6) 82
The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge. 82
Vagal reflexes following an exercise stress test: a simple clinical tool for gene-specific risk stratification in the long QT syndrome. 82
Ion channel diseases in children: manifestations and management. 82
Gene symbol: KCNH2 82
Identification of Cadherin 2 (CDH2) Mutations in Arrhythmogenic Right Ventricular Cardiomyopathy. 82
Gene symbol: KCNH2. 81
Refined multiscale entropy analysis of heart period and QT interval variabilities in long QT syndrome type-1 patients2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) 81
Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel. 79
Gene expression and arrhythmic risk. 79
Drug-induced long QT syndrome and exome sequencing: Chinese shadows link past and future. 79
Gene symbol: KCNQ1. 79
Congenital Short QT Syndrome 78
Gene symbol: KCNH2. 77
Totale 10.557
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.358
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.358
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202113 0 0 0 0 0 0 0 0 0 0 0 13
2021/2022577 13 5 33 7 13 18 7 43 34 6 90 308
2022/20232.247 232 152 27 246 194 221 2 108 907 6 124 28
2023/2024820 92 136 22 53 73 196 23 77 5 30 65 48
2024/20252.079 45 178 62 51 46 116 103 174 526 74 220 484
2025/20264.752 376 391 519 429 622 202 878 225 426 330 206 148
Totale 13.938